- What’s driving orthopedic outcomes, sustainability
- FDA warns 30 telehealth firms over compounded GLP-1 claims
- Cedars-Sinai AI tool predicts best chemotherapy for pancreatic cancer patients
- MUSC Health buys primary care group for $111M
- Why private practice will survive in the DSO era
- Rehab hospitals with the most, fewest preventable readmissions
- Geisinger names new CFO
- ‘We’re running in when others are running out’: Stability drives record growth for regional Medicare Advantage plans
- ‘We’re running in when others are running out’: Stability drives record growth for regional Medicare Advantage plans
- Freshpaint elevates marketing chief to CEO
- California provider opens teen mental health center
- Catholic Health to outsource Epic support to Nordic
- Idaho GI group cuts appointment wait times with virtual platform
- Longtime Missouri hospital CEO retires
- 6 Texas physicians to pay $5M to settle false claims allegations
- Inside Huntsman’s hybrid model boosting social worker capacity sixfold
- 12 dental technology updates to know
- Imagen Dental Partners adds California practice
- South Carolina’s largest independent multispecialty group acquired
- Gastroenterology and private equity in 2026: 5 notes
- WHO calls for environmentally friendly, less invasive dental care: 5 notes
- The GI physician shortage by state, by 2036
- ASC vs. HOPD costs for 5 orthopedic procedures
- Federal lawmakers introduce bill to reverse Medicaid cuts, expand Medicare dental coverage: 4 notes
- Maryland awards $1.6M for substance use disorder, peer recovery workforce expansion
- SSM Health adds gastroenterologist
- 3 new ASCs in Florida
- Kaiser Permanente gets green light for 160K-square-foot ASC
- Mount Sinai, Saudi university partner on familial IBD research
- San Diego provider opens 32-bed residential mental health facility
- AI Therapist? It Falls Short, a New Study Warns
- Nevada hospital to downsize, switch to rural emergency status
- Moody’s downgrades Arkansas system’s credit rating
- Mental health providers subject to ban on youth ‘transition’ procedures: Texas attorney general
- Innovate 32 continues growth, adds 2 dental practices in Tennessee
- Grow Therapy scores $150M to build out enterprise partnerships with docs, employers
- Indiana hospital transitions revenue cycle operations to Revology
- Mayo Clinic posts 6.8% margin in 2025
- Nearly 20 States Scale Back HIV Medication Programs
- BBQ Sauce Recall Issued Nationwide Due To Incorrect Label
- FDA Recalls More Than 651,000 Jugs of Water Over Sanitation Concerns
- Listen to the Latest ‘KFF Health News Minute’
- Corewell Health posts 1.6% operating margin, grows revenue to $17.6B — 7 things to know
- Hasta los pacientes se sorprenden por los precios que sus aseguradoras están dispuestas a pagar, un costo que al final pagamos todos
- Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient
- Guardant picks Patrick Dempsey for colorectal cancer blood test awareness
- Breast Cancer Cases, Deaths Expected To Rise Worldwide
- Collagen Supplements Good For Skin, Arthritis, Evidence Review Concludes
- Illicit Adderall Use Places Stress On The Heart, Study Shows
- A-Fib Drug, Diltiazem, Could Interact With Blood Thinners, Increase Risk Of Dangerous Bleeding
- How to Get Ready For Daylight Saving Time
- Effective Sunscreen Protection Can Cost $40 A Year
- Longtime Cigna CEO David Cordani to retire, Brian Evanko tapped as successor
- Acadia, undaunted by recent EU rejection, seeks CHMP re-examination of Rett syndrome med Daybue
- FDA’s CRLs reveal critical errors in AstraZeneca’s Saphnelo data, efficacy doubts for GSK’s Exdensur
- Readers Lean On Congress To Solve Crises in Research and Rehab
- Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
- Federal Aid for Lead Cleanup Is Receding. That’s a Problem for Cash-Strapped Cities.
- Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
- Novo plugs $500M into Ireland plant to produce Wegovy pill for markets outside US
- Esperion pays $75M-plus to acquire Corstasis and newly approved Enbumyst
- The dental workforce trends that will dominate 2026
- Federal Medicaid cuts threaten dental care access: See the potential impact by state
- Children’s Mercy raises $150M for mental healthcare
- California awards $291M to expand behavioral health housing, services
- OhioHealth builds well-being programs to reshape caregiver culture
- Lawmakers introduce bill to reverse Medicaid cuts, expand Medicare benefits
- New Jersey woman charged with practicing unlicensed dentistry
- 100+ organizations call on CMS to revise 2027 MA rates
- Oklahoma advances interstate compact bill
- UNC Health Appalachian offers psychiatric physician training program
- Colorado Medicaid ABA audit finds $77.8M in improper payments
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- In 1 state, large hospitals dominate 340B's net savings
- CMS to suspend enrollment into Elevance’s Medicare Advantage plans
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Providers urge Education Department to reconsider which jobs face stiffer student loan caps
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Families Defend Disability Services Amid Medicaid Cuts
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover
- Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel
- CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- Clover Health CEO said company sees opportunity in complex MA environment
- How pharma marketers are capturing the power of podcasts to connect with consumers
- Cigna's Evernorth quietly acquires hospital pharmacy CarepathRx
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- Patrick Kennedy: Collab with MAHA is essential to address mental health crisis
- Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
- Alignment CEO John Kao offers measured response to proposed 2027 MA rates
- Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign
- Op-ed: Our patients deserve better safety reporting. AI could be the answer
- After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific review'
- Blood Test Can Predict Short-Term Survival Among Seniors
- How the Brain Learns to Have Seizures During Sleep
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
- Wildfire Smoke Linked To Increase In Violent Assaults
- More Parents Are Refusing A Life-Saving Shot For Their Newborns, Study Finds
- To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
- Lake Nona Impact Forum: There can't be longevity without tech
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Smith+Nephew signs distribution agreement with SI-BONE
- Smith+Nephew signs distribution agreement with SI-BONE
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Partnering to Advance Drug Delivery Innovation
- How Pharma is Expanding its Global Footprint to Advance Clinical Research
- Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model
- CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Democrat-Led States Sue Trump Administration Over Cuts to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
The NIH's rate change notice capping indirect costs on research grants has brought out the lunatics in academe. American Prospect is demanding that President Trump follow the science funding policies of Adolf Hitler. The author, Robert Kuttner is co-founder and co-editor of The American Prospect, and a professor at Brandeis University’s Heller School for Social Policy and Management in Waltham, Massachusetts. Somehow, Dr. Kuttner fails to mentions Hitler's most notable medical/scientific innovations, Aktion T4 and Organization Wirths in their Konzentrationslager:
https://prospect.org/politics/2025-02-10-what-trump-could-learn-from-hitler-on-nih-funding/
What Trump Could Learn From Hitler on NIH Funding
Even the Führer knew to support German science, and not just for war. Why is Trump trying to destroy America’s great research universities?By Robert Kuttner - February 10, 2025
On Friday, the National Institutes of Health announced that it is capping the amount of overhead on all research grants to 15 percent. Overhead pays for everything from the cost of research labs to the expense of applying for grants to administrator salaries to the cost of filing patent applications.
The average overhead has been running at about 26 percent, and at some top research universities such as Harvard, Yale, and Johns Hopkins, it is over 60 percent. The administration also plans to cut funding for the National Science Foundation by at least two-thirds.
NIH and NSF are a big part of why the U.S. is the world’s leader in science and technology. In 2023, NIH distributed about $35 billion through about 50,000 grants to over 300,000 researchers. Nine billion of this was overhead. Shrinking overhead will reduce these universities’ ability to conduct research.
Why is Trump doing this? Is this assault on NIH the war against the deep state on autopilot? Something very similar was in the Project 2025 blueprint. Is Trump trying to punish big research universities in blue states? Is it simple nihilism?
One source of Trump’s wreckage of state support for science and technology is Elon Musk. When Musk and his small team of engineers working in a garage were inventing the first private space rocket, they found they could do it a lot more cheaply than NASA, which was hidebound by elaborate rules and specifications that added needless costs.
Just two years after Musk launched his first successful rocket into orbit in 2008, it was Barack Obama who ordered NASA to contract out rocket launches to Musk to save costs. For Musk, the takeaway was that science and technology doesn’t need government.
But of course, it is government via NASA that ultimately pays for SpaceX. And biotech research is a whole other story from rocketry. It can’t be done in a garage; it requires labs, teams of researchers, and careful clinical trials.
NIH and NSF grants aren’t the deep state. The money doesn’t stay in Washington; it goes out to finance research. And a lot of major research universities are in red or purple states.
Heather Cox Richardson reported that eight Florida research universities will lose $165 million. Six in Ohio will lose $194 million; and four in Missouri will lose $212 million. And that doesn’t count the cost of future lost grants that universities will lack the capacity to apply for.
It’s one thing to trash USAID. In the view Trump and Musk have tried to cement with the public, the benefits go to a bunch of foreigners, often in shithole countries, sometimes to promote DEI. (This of course is total BS. USAID mainly alleviates starvation and disease, and prevents China from dominating the Global South.)
But it’s something else to destroy the world-class institutions that make America great, to coin a phrase. Even Hitler did not trash German science.
Hitler did seek to turn science to his own ends, to promote research on eugenics, new technologies for blitzkrieg war, sick medical experiments, and more efficient ways for the mass killing of Jews. Yet civilian German science, long a mark of German pride, also thrived. During the Nazi era, German scientists and engineers invented the first electron microscope, industrial-scale production of artificial fiber, pharmaceuticals such as advanced sulfa drugs, artificial rubber, and much more.
Trump, in short, is even more nihilist than Hitler.
WE AWAIT THE PUSHBACK. Surely university leaders as well as governors and private-sector research clients in red states are already in touch with their legislative representatives in Washington. Are Republican House and Senate members so thoroughly intimidated by Trump that they won’t push back? We’ll soon find out.
When OMB issued its first lunatic order pausing virtually all federal grants-in-aid, even before the illegal move was enjoined by two federal judges, OMB began walking the order back. This was mainly because of massive pushback from red states. It would be surprising if something similar did not happen with the NIH order. Already, Republican Alabama Sen. Katie Britt is vowing to work to restore NIH funding to the universities in her home state.
As for NSF, its funding will be part of the coming battle over budget reconciliation. Of all the things that Republican legislators will give up in the negotiations, it’s hard to imagine them going to the mat with Democrats in order to cripple NSF.
As law professor Sam Bagenstos has reported, the NIH order is also probably illegal. In 2017, during Trump’s first administration when an assault on NIH was rumored, Congress attached a rider to the NIH appropriation requiring that NIH must not deviate from the formulas for indirect costs that were applied in the third quarter of FY2017.
As Bagenstos points out, the memo implementing the new policy also violates the Administrative Procedure Act, which requires a rulemaking and notice and comment for such a drastic change. Once again, there will be litigation and we will find out whether we can rely on the courts.
My informed hunch is that the 15 percent rule will be walked back first. Small-d democratic politics, battered but unbroken, to the rescue.
BMW 7 Series luxury sedans have a sick hold on our truly undistinguished academic culture. They will do anything, other than quality research, to live the luxe life.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















